High-dose ulinastatin to prevent late-onset acute renal failure after orthotopic liver transplantation

PURPOSE: To compare the efficacy and safety of two distinct doses of ulinastatin on late-onset acute renal failure (LARF) following orthotopic liver transplantation (OLT). METHODS: The high-risk recipients that underwent OLT were divided into two groups according to ulinastatin dose: low-dose (LD) u...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Haijin, Wei, Xuxia, Yi, Xiaomeng, Liu, Jianrong, Lu, Pinglan, Zhou, Mi, An, Yuling, Yi, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034081/
https://www.ncbi.nlm.nih.gov/pubmed/31984833
http://dx.doi.org/10.1080/0886022X.2020.1717530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034081/
https://www.ncbi.nlm.nih.gov/pubmed/31984833
http://dx.doi.org/10.1080/0886022X.2020.1717530

Ejemplares similares